Net profit of Morepen Laboratories rose 17.27% to Rs 40.87 crore in the quarter ended September 2025 as against Rs 34.85 crore during the previous quarter ended September 2024. Sales declined 5.97% to Rs 411.58 crore in the quarter ended September 2025 as against Rs 437.73 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 411.58 | 437.73 | -6 |
| OPM % | 7.46 | 10.07 | - |
| PBDT | 31.15 | 47.88 | -35 |
| PBT | 19.86 | 46.02 | -57 |
| NP | 40.87 | 34.85 | 17 |